PMA device
Medstream Programmable Infusion System
Intera Oncology · Pump, Infusion, Implanted, Programmable (LKK, Class III) · First FDA decision Mar 15, 2011, newest Dec 17, 2014Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
1
Naming "Medstream"
MAUDE reports
96
Brand "Medstream", since 2015
PubMed studies
8
Mentioning "Medstream"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medstream Programmable Infusion System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- MEDSTREAM PROGRAMMABLE INFUSION SYSTEMPMA supplement
P890055-S058 · Decided Dec 17, 2014 · 68 days after receipt · Normal 180 Day Track No User Fee
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- MEDSTREAM PROGRAMMABLE INFUSION SYSTEMPMA supplement
P890055-S031 · Decided Feb 12, 2013 · 756 days after receipt · Normal 180 Day Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- MEDSTREAM PROGRAMMABLE INFUSION SYSTEMPMA supplement
P890055-S030 · Decided Mar 15, 2011 · 56 days after receipt · Normal 180 Day Track No User Fee
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Medstream", any status and sponsor, newest update first.
Codman & ShurtleffNot on our public-company list
NCT01712087 · 2 participants · Start Oct 1, 2012 · Primary completion Dec 17, 2017
Device: MedStream Programmable Infusion System · For: Spasticity
Sites: Worcester, Massachusetts; Houston, Texas
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Medstream", and for the whole product code for context.
This brand
96 reports: 18 malfunction, 77 injury, 1 death
Whole product code LKK
71,356 reports: 25,333 malfunction, 45,674 injury, 326 death
Newest reports for this brand
- MedstreamInjury
2124215-2026-48572 · Received Sep 10, 2026 · Event dated Jan 1, 2016
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
- MEDSTREAMMalfunction
MEDICAL SPECIALTIES DISTRIBUTORS, INC.
22736662 · Received Aug 7, 2025 · Event dated Dec 3, 2024
Device type: Set, Administration, Intravascular (FPA)
Device problem as coded: Connection Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- MEDSTREAMMalfunction
MEDICAL SPECIALTIES DISTRIBUTORS, INC.
22736701 · Received Aug 7, 2025 · Event dated Dec 3, 2024
Device type: Set, Administration, Intravascular (FPA)
Device problem as coded: Connection Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, implantable drug delivery deviceCompleted
Z-2580-2026 · Started May 11, 2026 · Posted by FDA Jun 25, 2026
Reason given: There is the potential for leakage along the drug pathway from the pump through the end of the catheter.
Cause as FDA categorized it: Process control · Device type: Pump, Infusion, Implanted, Programmable (LKK)
- INTERA 3000 Hepatic Artery Infusion Pump, 30 mL, Sterile, Rx Only. implantable infusion pump.Terminated
Z-1522-2022 · Started Jul 10, 2022 · Posted by FDA Aug 22, 2022
Reason given: Higher than expected flow rate.
Cause as FDA categorized it: Process design · Device type: Pump, Infusion, Implanted, Programmable (LKK)
Z-1571-2014 · Started Nov 10, 2015 · Posted by FDA May 9, 2014
Reason given: A small number of specific pumps may trigger a low battery alarm at the beginning of the implanted life.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Implanted, Programmable (LKK)
12 more recall records with a free account
Published research
The most relevant PubMed records for "Medstream"[tiab]. The summary above synthesizes these.
- "Sonology" of programmable intrathecal pumps.
Saulino M, Gofeld M · Neuromodulation · 2014
- Convection enhanced delivery of different molecular weight tracers of gadolinium-tagged polylysine.
Hardy PA, Keeley D, Schorn G, et al. · J Neurosci Methods · 2013Research Support, Non-U.S. Gov't
- Programmable infusion pump and catheter: evaluation using 3-tesla magnetic resonance imaging.
Shellock FG, Crivelli R, Venugopalan R · Neuromodulation · 2008
- [Complications of intrathecal baclofen therapy].
Paskhin DL, Dekopov AV, Tomsky AA, et al. · Zh Vopr Neirokhir Im N N Burdenko · 2017
- Solubility and Stability of Baclofen 3 mg/mL Intrathecal Formulation and Its Compatibility With Implantable Programmable Intrathecal Infusion Systems.
Yue B, Brendel R, Lukitsch A, et al. · Neuromodulation · 2017
- In vivo study of flow-rate accuracy of the MedStream Programmable Infusion System.
Venugopalan R, Ginggen A, Bork T, et al. · Neuromodulation · 2011Evaluation Study
- An in vivo canine study to assess granulomatous responses in the MedStream Programmable Infusion System (TM) and the SynchroMed II Infusion System®.
Michael A, Buffen E, Rauck R, et al. · Pain Med · 2012Comparative Study
- Assessment of telemetry and fluidic control system used in the Medstream programmable infusion system: an in vivo and in vitro study.
Bork T, Crivelli R, Tardy Y, et al. · Biomed Microdevices · 2014
Other devices of this type
Also filed under product code LKK.
- SynchroMed Infusion System, Ascenda Intrathecal CathetersMedtronic, Inc. · PMA 2026
- Prometra Programmable Infusion Pump SystemInfusyn Therapeutics, LLC · PMA 2025
- Synchromed II Pump RemediationMedtronic, Inc. · PMA 2017
- Implantable System for RemodulinMedtronic, Inc. · PMA 2021
- IsoMed Infusion SystemMedtronic, Inc. · PMA 2023
- INFUSAID Implantable Infusion Pump and AccessoriesIntera Oncology · PMA 2020
- Medtronic(R) Synchromed(Tm) Pump & Infusion SystemMedtronic, Inc. · PMA 2018
- 3000 Series Implantable Infusion Pump and the MedStream Programmable Infusion System and AccessoriesIntera Oncology · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.